spectinomycin has been researched along with 2019 Novel Coronavirus Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chávez-Ríos, AR; Colín-Ugalde, AG; Galindo-Fraga, A; González-González, R; González-Lara, MF; Haro-Osnaya, A; Huertas-Jiménez, MA; Leal-Morán, PE; Ochoa-Hein, E; Paz-García, R; Ponce-de-León, A; Rajme-López, S; Sifuentes-Osornio, J; Vargas-Fernández, AT; Vargas-Fernández, JF | 1 |
1 other study(ies) available for spectinomycin and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Prevention of COVID-19 superspreading events in buses boarded by presymptomatic cases.
Topics: COVID-19; COVID-19 Vaccines; Humans; Motor Vehicles; Prospective Studies; SARS-CoV-2; Spectinomycin | 2022 |